Cis-platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC gastrointestinal tract cancer cooperative group
Tài liệu tham khảo
MacDonald, 1982, Cancer of the stomach, 534
Lacave, 1979, Methyl-CCNU (Me), 5-fluorouracil (F), adriamycin (A) (MeFA) versus MeF in advanced gastric cancer, 20, 310
MacDonald, 1980, 5-Fluorouracil, doxorubicin, mitomycin-C (FAM) combination chemotherapy for advanced gastric cancer, Ann Intern Med, 93, 535, 10.7326/0003-4819-93-4-533
The Gastrointestinal Tumor Study Group, 1979, Phase II–III chemotherapy studies in advanced gastric cancer, Cancer Treat Rep, 63, 1871
Douglas, 1984, An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin-C, adriamycin and 5-fluorouracil in advanced measurable gastric cancer (EST 2277), J Clin Oncol, 2, 1312
The Gastrointestinal Tumor Study Group, 1984, Randomized study of combination chemotherapy in unresectable gastric cancer, Cancer, 53, 13, 10.1002/1097-0142(19840101)53:1<13::AID-CNCR2820530104>3.0.CO;2-0
Heim, 1984, Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, adriamycin (doxorubicin) and mitomycin-C (modified FAM), Cancer, 54, 1999, 10.1002/1097-0142(19841101)54:9<1999::AID-CNCR2820540935>3.0.CO;2-E
Lacave, 1985, A randomized trial of MeFA vs FA in advanced gastric cancer, 4, 78
Cullinan, 1984, A randomized comparison of 5-FU alone (F), 5-FU and adriamycin (FA), and 5-FU + adriamycin + mitomycin C (FAM) in gastric and pancreatic cancer, 3, 137
Loehrer, 1984, Cisplatin, Ann Intern Med, 100, 704, 10.7326/0003-4819-100-5-704
Izarzugaza, 1979, Phase II clinical study of CDDP in gastric cancer resistent to chemotherapy
Lacave, 1983, Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer, Am J Clin Oncol, 6, 35, 10.1097/00000421-198302000-00005
1979
Beer, 1983, A phase II study of cisplatin in advanced gastric cancer, Eur J Cancer Clin Oncol, 19, 717, 10.1016/0277-5379(83)90003-2
Leichman, 1984, Cisplatin: an active drug in the treatment of disseminated gastric cancer, Cancer, 53, 18, 10.1002/1097-0142(19840101)53:1<18::AID-CNCR2820530105>3.0.CO;2-J
Vogl, 1984, Cis-Platinum in refractory gastric cancer, 24, 147
Lee, 1981, Statistical contribution to phase II trials in cancer: interpretation, analysis and design, Semin Oncol, 8, 403
Woolley, 1981, A phase II trial of 5-FU, adriamycin and cisplatin (FAP) in advanced gastric cancer, 22, 455
Wagener, 1983, A phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer, 2, 115
Moertel, 1984, A phase II trial of combined intensive course 5-FU, adriamycin and cis-platinum in advanced gastric cancer and pancreatic carcinoma, 3, 137